Springworks Therapeutics, Inc.

This study tested an experimental drug called nirogacestat in patients with a rare type of ovarian cancer (granulosa cell tumor) that had returned after prior treatment. The goal was to see if the drug could shrink tumors and control the disease. The trial enrolled 53 adults whos…